Department of BioMechanical Engineering, Delft University of Technology, Mekelweg 2, 2628 CD Delft, The Netherlands.
J Biomed Mater Res B Appl Biomater. 2013 Jul;101(5):700-8. doi: 10.1002/jbm.b.32872. Epub 2013 Jan 29.
In this study, a porous oxide layer was formed on the surface of nickel-titanium alloy (NiTi) by plasma electrolytic oxidation (PEO) with the aim to produce a polymer-free drug carrier for drug eluting stent (DES) applications. The oxidation was performed galvanostatically in concentrated phosphoric acid electrolyte at low temperature. It was found that the response of NiTi substrate during the PEO process was different from that of bulk Ti, since the presence of large amount of Ni delayed the initial formation of a compact oxide layer that is essential for the PEO to take place. Under optimized PEO conditions, the resultant surface showed porosity, pore density and oxide layer thickness of 14.11%, 2.40 × 10⁵ pores/mm² and 0.8 μm, respectively. It was additionally noted that surface roughness after PEO did not significantly increase as compared with that of original NiTi substrate and the EDS analyses revealed a decrease in Ni/Ti ratio on the surface after PEO. The cross-section morphology showed no discontinuity between the PEO layer and the NiTi substrate. Furthermore, wettability and surface free energy of the NiTi substrate increased significantly after PEO treatment. The PEO process could be successfully translated to NiTi stent configuration proving for the first time its feasibility for such a medical device and offering potential for development of alternative, polymer-free drug carriers for NiTi DES.
在这项研究中,通过等离子体电解氧化(PEO)在镍钛合金(NiTi)表面形成多孔氧化层,旨在生产用于药物洗脱支架(DES)应用的无聚合物药物载体。氧化是在低温下在浓磷酸电解质中进行恒电流的。研究发现,NiTi 基体在 PEO 过程中的反应与大块 Ti 不同,因为大量 Ni 的存在延迟了形成对于 PEO 发生至关重要的致密氧化层的初始形成。在优化的 PEO 条件下,所得表面的孔隙率、孔密度和氧化层厚度分别为 14.11%、2.40×10⁵ 个/平方毫米和 0.8 微米。此外,还注意到 PEO 后表面粗糙度与原始 NiTi 基体相比没有显著增加,EDS 分析表明 PEO 后表面的 Ni/Ti 比值降低。横截面形态显示 PEO 层和 NiTi 基体之间没有不连续性。此外,NiTi 基体的润湿性和表面自由能在 PEO 处理后显著增加。PEO 工艺可以成功地转化为 NiTi 支架结构,首次证明了其在这种医疗器械中的可行性,并为开发用于 NiTi DES 的替代、无聚合物药物载体提供了潜力。